Warrants - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Jan. 09, 2020 |
Sep. 30, 2020 |
Sep. 30, 2020 |
Aug. 21, 2020 |
Sep. 22, 2017 |
|
Class Of Warrant Or Right [Line Items] | |||||
Purchase of common stock upon exercise of warrants | 410,239 | ||||
Warrants initial exercise price | $ 0.01 | ||||
Warrant expense | $ 1,525 | $ 3,109 | |||
OrbiMed Royalty & Credit Opportunities, LP. | |||||
Class Of Warrant Or Right [Line Items] | |||||
Purchase of common stock upon exercise of warrants | 410,239 | ||||
Warrants initial exercise price | $ 16.10 | ||||
Unamortized debt discount | 2,064 | 2,064 | |||
Warrant expense | $ 2,359 | $ 1,525 | $ 3,109 | ||
OrbiMed Royalty & Credit Opportunities, LP. | Warrants | |||||
Class Of Warrant Or Right [Line Items] | |||||
Fair value of the Warrants | $ 2,359 |